Related Experiment Video
Updated: Jan 23, 2026

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
Qingsong Hu1, Youqiong Ye2, Li-Chuan Chan1,3
1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
How tumor cells genetically lose antigenicity and evade immune checkpoints remains largely elusive. We report that tissue-specific expression of the human long noncoding RNA LINK-A in mouse mammary glands initiates metastatic mammary gland tumors, which phenotypically resemble human triple-negative breast cancer (TNBC). LINK-A expression facilitated crosstalk between phosphatidylinositol-(3,4,5)-trisphosphate and inhibitory G-protein-coupled receptor (GPCR) pathways, attenuating protein kinase A-mediated phosphorylation of the E3 ubiquitin ligase TRIM71. Consequently, LINK-A expression enhanced K48-polyubiquitination-mediated degradation of the antigen peptide-loading complex (PLC) and intrinsic tumor suppressors Rb and p53. Treatment with LINK-A locked nucleic acids or GPCR antagonists stabilized the PLC components, Rb and p53, and sensitized mammary gland tumors to immune checkpoint blockers. Patients with programmed ccll death protein-1(PD-1) blockade-resistant TNBC exhibited elevated LINK-A levels and downregulated PLC components. Hence we demonstrate lncRNA-dependent downregulation of antigenicity and intrinsic tumor suppression, which provides the basis for developing combinational immunotherapy treatment regimens and early TNBC prevention.
Insights
The long noncoding RNA LINK-A drives triple-negative breast cancer (TNBC) by reducing tumor antigen presentation and immune evasion. Targeting LINK-A may improve immunotherapy response in PD-1 blockade-resistant TNBC.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Tumor cells evade immune surveillance by losing antigenicity and immune checkpoints, a mechanism not fully understood.
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options.
Purpose of the Study:
- To investigate the role of the long noncoding RNA LINK-A in TNBC development and immune evasion.
- To explore potential therapeutic strategies targeting LINK-A for improved immunotherapy outcomes.
Main Methods:
- Utilized mouse models with tissue-specific LINK-A expression to induce mammary gland tumors.
- Investigated molecular pathways involving phosphatidylinositol-(3,4,5)-trisphosphate, G-protein-coupled receptors (GPCRs), and TRIM71.
- Assessed the impact of LINK-A on the antigen peptide-loading complex (PLC), Rb, and p53.
- Evaluated therapeutic interventions using LINK-A locked nucleic acids and GPCR antagonists.
- Correlated LINK-A levels and PLC components with patient responses to PD-1 blockade in TNBC.
Main Results:
- LINK-A expression initiated metastatic mammary tumors resembling human TNBC.
- LINK-A disrupted signaling pathways, leading to enhanced degradation of PLC, Rb, and p53.
- Therapeutic targeting of LINK-A or GPCRs restored PLC, Rb, and p53 levels, sensitizing tumors to immune checkpoint blockers.
- Elevated LINK-A and reduced PLC components were observed in PD-1 blockade-resistant TNBC patients.
Conclusions:
- lncRNA-dependent downregulation of antigenicity and tumor suppression contributes to TNBC immune evasion.
- LINK-A represents a potential therapeutic target for enhancing immunotherapy efficacy in TNBC.
- Findings suggest combinational immunotherapy and early TNBC prevention strategies targeting LINK-A.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Self-Presentation
Intrinsically Disordered Proteins
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Self-Presentation: Self-Monitoring and Self-Handicapping

